Discontinuation report PACLITAXEL FOR INJECTION

Last updated on 2018-02-01 History
Report ID 15446
Drug Identification Number 02296624
Brand name PACLITAXEL FOR INJECTION
Common or Proper name Paclitaxel
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PACLITAXEL
Strength(s) 6MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5mL & 16.7mL & 50mL
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-01-31
Remaining supply date 2018-01-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-02-01 English Compare
v4 2017-07-11 French Compare
v3 2017-07-11 English Compare
v2 2017-07-11 French Compare
v1 2017-07-11 English Compare

Showing 1 to 5 of 5